Piet van der Graaf

Piet van der Graaf

Company: Certara

Job title: Senior Vice President, Head of Quantitative Systems Pharmacology


Biosimulation Model-informed Gene Therapy Development: Predicting Human Dose and Immunogenicity 12:00 pm

Regulatory-ready IG simulator developed in consortium with eight pharmaceutical companies, now licensed by FDA Applied to gene therapy for predicting human dose from pre-clinical data, to translational phases, and through clinical development Case studies highlighting application to various modalities: AAV, mRNA and gene editingRead more

day: Day 1 Tracks 2 AM

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.